Segment information

Business segments1

2016
Continuing operations
Discon-
tinued operations
Elimina-
tions
Total
Nutrition
Materials
Innovation Center
Corporate
Activities2
Elimina-
tions
Total
Financial performance
         
Net sales
5,169
2,513
167
71
-
7,920
-
-
7,920
Supplies to other clusters
55
7
23
-
(85)
-
-
-
-
          
Supplies
5,224
2,520
190
71
(85)
7,920
-
-
7,920
          
Adjusted EBITDA
931
435
1
(105)
-
1,262
-
-
1,262
EBITDA
934
419
(5)
(174)
-
1,174
(28)
-
1,146
Adjusted operating profit
645
311
(24)
(141)
-
791
-
-
791
Operating profit
648
285
(38)
(210)
-
685
(28)
-
657
          
Depreciation and amortization
278
124
24
34
-
460
-
-
460
Impairments
8
10
9
2
-
29
-
-
29
- of which included in APM adjustments
-
10
8
-
-
18
-
-
18
Additions to provisions
4
15
3
77
-
99
-
-
99
Share of the profit of associates and joint ventures
-
7
(24)
211
-
194
-
-
194
R&D costs3
104
109
64
32
-
309
-
-
309
Wages, salaries and social security costs
902
332
78
309
-
1,621
-
-
1,621
          
Financial position
         
Total assets
6,935
2,207
826
2,990
-
12,958
-
-
12,958
Total liabilities
1,857
774
84
4,063
-
6,778
-
-
6,778
Capital employed at year-end
5,537
1,807
576
(31)
-
7,889
-
-
7,889
Capital expenditure
331
106
32
16
-
485
-
-
485
Share in equity of associates and joint ventures
1
2
133
450
-
586
-
-
586
          
Adjusted EBITDA margin (in %)
18.0
17.3
   
15.9
-
 
15.9
          
Workforce
         
Average in FTE
13,168
4,453
613
2,275
-
20,509
-
-
20,509
Year-end (headcount)
13,260
4,460
619
2,447
-
20,786
-
-
20,786

1 For a description of the types of products and services of each segment please refer to the 'Review of business' in the 'Report by the Managing Board'. Supplies between segments were fairly limited and were generally executed at market-based prices.

2 Corporate Activities also includes costs for regional holdings, corporate overhead and share-based compensation.

3 R&D costs relate to the functional area Research and development and exclude R&D cost included in the functional areas Cost of sales and Marketing and sales as well as R&D expenditure capitalized.

Business segments1

2015
Continuing operations
Discon-
tinued
operations
Elimina-tions
Total
Nutrition
Materials
Innovation Center
Corporate Activities 2
Elimina-tions
Total
Financial performance
         
Net sales
4,963
2,528
155
76
-
7,722
1,213
-
8,935
Supplies to other clusters
56
19
3
-
(61)
17
253
(270)
-
          
Supplies
5,019
2,547
158
76
(61)
7,739
1,466
(270)
8,935
          
Adjusted EBITDA
822
384
(9)
(122)
-
1,075
95
-
1,170
EBITDA
791
379
(27)
(187)
-
956
90
-
1,046
Adjusted operating profit
535
250
(43)
(169)
-
573
77
-
650
Operating profit
495
185
(66)
(252)
-
362
(58)
-
304
          
Depreciation and amortization
271
133
28
43
-
475
13
-
488
Impairments
25
61
11
22
-
119
135
-
254
- of which included in APM adjustments
9
60
5
18
-
92
130
-
222
Additions to provisions
3
23
-
55
-
81
1
-
82
Share of the profit of associates and joint ventures
-
3
(18)
45
-
30
-
-
30
R&D costs3
123
109
70
30
-
332
8
-
340
Wages, salaries and social security costs
859
319
71
320
-
1,569
82
-
1,651
          
Financial position
         
Total assets
6,523
2,122
809
2,289
-
11,743
-
-
11,743
Total liabilities
1,755
791
77
3,489
-
6,112
-
-
6,112
Capital employed at year-end
5,309
1,723
560
(39)
-
7,553
-
-
7,553
Capital expenditure
322
98
34
24
-
478
92
-
570
Share in equity of associates and joint ventures
1
7
135
501
-
644
-
-
644
          
Adjusted EBITDA margin (in %)
16.6
15.2
   
13.9
7.8
 
13.1
          
Workforce
         
Average in FTE
13,474
4,463
625
2,065
-
20,627
1,238
-
21,865
Year-end (headcount)
12,978
4,472
630
2,716
-
20,796
-
-
20,796

1 For a description of the types of products and services of each segment please refer to the 'Review of business' in the 'Report by the Managing Board'. Supplies from DSM Fibre Intermediates to DSM Engineering Plastics were executed at cost until deconsolidation. Transfers between other segments were fairly limited and were generally executed at market-based prices.

2 Corporate Activities also includes costs for regional holdings, corporate overhead and share-based compensation.

3 R&D costs relate to the functional area Research and development and exclude R&D costs included in the functional areas Cost of sales and Marketing and sales as well as R&D expenditure capitalized.

Geographical information

2015
Continuing operations
 
The Nether-lands
Rest of Western Europe
Eastern Europe
North America
Latin America
China
India
Japan
Rest of Asia
Rest of the world
Total
Net sales by origin
           
In € million
1,938
2,123
154
1,451
719
837
76
73
272
79
7,722
In %
25
27
2
19
9
11
1
1
4
1
100
            
Net sales by destination
           
In € million
280
1,851
467
1,779
1,053
937
153
209
740
253
7,722
In %
4
24
6
23
13
12
2
3
10
3
100
            
Workforce at year-end (headcount)
4,166
4,732
439
3,161
2,020
4,556
501
144
821
256
20,796
Average workforce (FTE)
4,017
4,589
426
3,153
2,164
4,534
516
144
832
252
20,627
            
Intangible assets and Property, plant and equipment
           
Capital expenditure
138
121
2
102
22
84
2
-
5
2
478
Carrying amount
1,619
1,238
29
2,537
292
505
19
22
117
21
6,399
            
Total assets (total DSM)
3,838
2,038
119
3,486
749
882
82
95
361
93
11,743
            
2016
 
Net sales by origin
           
In € million
2,006
2,444
160
1,436
544
842
73
100
241
74
7,920
In %
25
31
2
18
7
11
1
1
3
1
100
            
Net sales by destination
           
In € million
303
1,877
494
1,795
989
989
178
264
787
244
7,920
In %
4
25
6
23
12
12
2
3
10
3
100
            
Workforce at year-end (headcount)
4,026
4,715
439
3,187
2,069
4,594
475
193
828
260
20,786
Average workforce (FTE)
3,944
4,575
435
3,153
2,065
4,581
498
163
823
272
20,509
            
Intangible assets and Property, plant and equipment
           
Capital expenditure
120
151
4
91
36
73
1
1
5
3
485
Carrying amount
1,587
1,703
31
2,104
376
523
18
42
104
25
6,513
            
Total assets (total DSM)
4,560
2,495
126
3,110
885
1,077
87
144
367
107
12,958

DSM has no single external customer that represents 10% or more of revenues, and therefore information about major customers is not provided.